Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Asian Journal of Animal and Veterinary Advances
  Year: 2016 | Volume: 11 | Issue: 1 | Page No.: 17-23
DOI: 10.3923/ajava.2016.17.23
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Metronomic Chemotherapy in Small Animal Practice: An Update
Carlos Eduardo Fonseca-Alves and Sabryna Gouveia Calazans

Abstract:
Metronomic chemotherapy can be considered a new chemotherapy modality involving continuous administration of low doses of cytostatic agents which targets endothelial cells. Endothelial cells are vital for the development of new blood vessels and are essential for tumour growth. Furthermore, these cells are genetically stable, divide at a high rate and do not acquire resistance to cytotoxic drugs as tumour cells. Therefore, they are sensitive to low doses of cytostatics. Because of the importance of metronomic chemotherapy in veterinary medicine, this review provides an update of the status of metronomic chemotherapy in small animal practice. In dogs with cancer, metronomic chemotherapy can be considered a good treatment option and a first-line therapy. Further studies evaluating the levels of regulatory T cells Tregs and tumour microvessel density are needed to better understand the role of this therapeutic modality in different canine tumours.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Canine Prostate Cancer: Would the Dog be an Important Model for the Study of New Drugs?
How to cite this article:

Carlos Eduardo Fonseca-Alves and Sabryna Gouveia Calazans, 2016. Metronomic Chemotherapy in Small Animal Practice: An Update. Asian Journal of Animal and Veterinary Advances, 11: 17-23.

DOI: 10.3923/ajava.2016.17.23

URL: https://scialert.net/abstract/?doi=ajava.2016.17.23

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

       

       

Curve Bottom